Duncan McKechnie, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,437 shares at $475.30 ($1.2M) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Scheduled sale ($1.2M) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2026-02-26 | $2.4M | — | Filing → |